Divalproex Sodium Delayed Release Tablets: Latest News on Divalproex Sodium Delayed Release Tablets, Divalproex Sodium Delayed Release Tablets Updates, Divalproex Sodium Delayed Release Tablets Videos, Photos, Wiki, Topic

Share >

Share on Tumblr

Divalproex Sodium Delayed Release Tablets

News »
latest by relevance

Jubilant Life Sciences gets US FDA nod for anti-ulcer drug

Sep 07, 2011 at 15:28 | Source: Moneycontrol.com

Pharma company Jubilant Life Sciences has received US Food and Drug Administration (US FDA) approval for its abbreviated new drug application for Pantoprazole Sodium delayed release tablets in 20 mg and 40 mg strength.

Lupin's Divalproex Sodium Delayed-Release Tabs approved

Jul 31, 2008 at 18:28

Lupin Limited, announced today that its subsidiary in the US, Lupin Pharmaceuticals, Inc. (LPI) has received final approval for the Companys Abbreviated New Drug Application (ANDA) for Divalproex Sodium Delayed-Release Tablets, 125 mg, 250 mg and 500 mg from the U.S. Food and Drug Administration (USFDA).

Sun Pharma gets approval for Depakote delayed release tabs

Feb 15, 2008 at 12:22

Sun Pharmaceutical Industries Ltd. announced that USFDA has granted tentative approval for the Companys Abbreviated New Drug Application for generic Depakote, divalproex sodium delayed release tablets

Sun Pharma launches generic Protonix Tablets

Jan 30, 2008 at 11:42

Sun Pharma launches generic Protonix Tablets

Wockhardt gets US FDA approval

Jun 15, 2006 at 18:29

Wockhardt gets US FDA approval to market delayed release tablets in US.

Photos »

Follow moneycontrol.com

Facebook Twitter Google Plus RSS Wap SMS SMS Alert iPad iPhone Blackberry OVI Android Window

Explore Moneycontrol

STOCKS A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others

MUTUAL FUNDS A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.